The additional doses will be available for delivery before the end of the year, while shots that were purchased earlier are currently being distributed, the EU Commission said.
In the coming days, people in the United States and the United Kingdom will be among the first to receive a new breed of COVID-19 vaccine. The hope was that these updated vaccines — based on Omicron variants of the SARS-CoV-2 virus — would offer substantially greater protection than older vaccines based on the strain of the virus that emerged in 2019.
Regulators in China approved a COVID-19 vaccine mist for use as a booster dose, making it the first alternative to injectable vaccines used during the pandemic.
/cloudfront-us-east-2.images.arcpublishing.com/reuters/53IDYKW3PJI4VOZSHM4ADOSXDA.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/HFO6ZALAUNKODMMUGX5WZXHH54.jpg)
/cloudfront-us-east-2.images.arcpublishing.com/reuters/WET7VB5NVZJT5CMFVWZMXAU5VE.jpg)
